Physician

Kelly T. Mitchell, M.D.

According to 2025 Medicare claims, Kelly Mitchell, M.D. (NPI: 1811988751) practices ophthalmology in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER LUBBOCK (NPI: 1336198621; TIN: 75-2668014) and primary practice location at 79430-0002. Mitchell is affiliated with the Texoma Clinical Partners ACO, LLC (ACO ID: A4585), participating under the MSSP model.

Mitchell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 395 traditional Medicare patients, billed 14,352 HCPCS/CPT codes, and received $544,042 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 292 prescription claims across 73 beneficiaries totaling $17,168 in drug costs, led by Combigan (Brimonidine Tartrate/Timolol). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $30,725 to $17,168. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$472K$944K2015 Medicare payment: $729,414 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $944,048 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $855,640 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $749,112 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $681,705 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $680,938 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $675,148 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $633,128 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $771,249 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $544,042 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158057,021$729,414
20167006,283$944,048
20176155,071$855,640
20185404,428$749,112
20194844,103$681,705
20203773,962$680,938
20213754,566$675,148
20223865,257$633,128
202337518,739$771,249
202439514,352$544,042

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$24K$47K2015 Drug cost: $30,725 (USD; Tot_Drug_Cst)2016 Drug cost: $38,275 (USD; Tot_Drug_Cst)2017 Drug cost: $47,012 (USD; Tot_Drug_Cst)2018 Drug cost: $35,594 (USD; Tot_Drug_Cst)2019 Drug cost: $46,184 (USD; Tot_Drug_Cst)2020 Drug cost: $33,875 (USD; Tot_Drug_Cst)2021 Drug cost: $29,345 (USD; Tot_Drug_Cst)2022 Drug cost: $25,809 (USD; Tot_Drug_Cst)2023 Drug cost: $21,952 (USD; Tot_Drug_Cst)2024 Drug cost: $17,168 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201583311$30,725
201697382$38,275
201793443$47,012
201887408$35,594
201988527$46,184
202075380$33,875
202175278$29,345
202264210$25,809
202374232$21,952
202473292$17,168

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more332680$96
67028Injection of drug into eye123373$92
92134Imaging of retina285641$30
92250Photography of the retina206279$28
J2777Injection, faricimab-svoa, 0.1 mg6311,704$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CombiganBrimonidine Tartrate/Timolol13704$4,095
Prednisolone AcetatePrednisolone Acetate371,412$1,469
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat422,302$530
LatanoprostLatanoprost482,171$526
MoxifloxacinMoxifloxacin Hcl12386$445

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Kelly T. Mitchell, M.D.?

Tedicare shows public-source Medicare data for Kelly T. Mitchell, M.D. (NPI 1811988751), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kelly T. Mitchell, M.D. have ACO affiliation data?

Kelly T. Mitchell, M.D. is shown with ACO affiliation data for Texoma Clinical Partners ACO, LLC (MSSP, ACO ID A4585).

What billing organization is linked to Kelly T. Mitchell, M.D.?

Kelly T. Mitchell, M.D. is linked to TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER LUBBOCK (billing NPI 1336198621) in the available physician profile data.

Does Kelly T. Mitchell, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.